Regulatory niche Goldbug Strategies specializes in FDA regulatory consulting for molecular therapies, IVDs, and innovative digital technologies, presenting a clear target for sales outreach to biotech firms developing high-regulatory-barrier products.

Small firm agility With a lean team and entrepreneurial approach, the firm can offer flexible, rapid-response engagements to clients navigating evolving regulatory policy, appealing to startups and mid-sized companies seeking nimble regulatory support.

Tech-enabled delivery Utilize their tech stack and data-driven methods to position services around scalable regulatory programs, submissions planning, and compliance analytics for clients deploying complex platforms (NGS, PCR, immunoassays, LDTs).

Niche expertise leverage Market their deep FDA and platform-specific expertise to attract clients facing specialized regulatory hurdles in oncology, infectious diseases, and neurodegenerative areas, including distributed kits and DTC/OTC pathways.

Growth opportunities Given revenue in the low to mid seven figures and a clear regulatory focus, pursue upsell opportunities with existing clients for expanded project scopes, such as full regulatory program management or post-market compliance support.